Because NMN is expensive to manufacture, the market has been plagued by quality control issues. Independent lab testing of various brands sold on major e-commerce platforms has frequently revealed products containing little to no actual NMN, or high levels of heavy metals. For a buyer, "purity" is the most critical metric. Reputable suppliers typically provide a from a third-party lab to verify that the product is at least 98–99% pure and free of contaminants. The FDA and Regulatory Limbo

The primary driver behind NMN sales is the "NAD+ decline" theory of aging. As humans age, levels of NAD+ in the body drop significantly, which is linked to metabolic decay and age-related diseases. Research, largely pioneered by Dr. David Sinclair at Harvard, suggests that supplementing with NMN can effectively raise NAD+ levels, potentially improving insulin sensitivity, enhancing mitochondrial function, and protecting neurological health. This biological potential has created a massive global demand among "biohackers" and aging-conscious consumers. Quality and Purity Concerns

Buying NMN is no longer a simple transaction; it is an exercise in navigating modern biotechnology and regulatory law. While the promise of "turning back the clock" at a cellular level is powerful, the burden is on the consumer to verify the legitimacy of their source. As clinical trials continue to move from mice to humans, the clarity of NMN’s benefits—and its legal status—will likely stabilize, but for now, it remains a frontier market.

Navigating the NMN market requires a cautious, "buyer beware" approach. Beyond checking for third-party testing, consumers often choose between , the latter of which claims to improve absorption. Furthermore, because NMN is sensitive to light and heat, proper storage and "cold-chain" shipping are often markers of a high-quality brand. Conclusion